Orphan Europe

Orphan Europe Overview

Founded 1990
Status Acquired/​Merged
Employees 73
Latest Deal Type M&A
Financing Rounds 1

Orphan Europe General Information


Developer of orphan medicinal products. The company's orphan medicinal products include Cystadane, Cystagon, Normosang and Wilzin for metabolic disorders, enabling patients to access a wide range of products for their treatment under one roof.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • 70, avenue du Général de Gaulle
  • 92800 Puteaux
  • France
+33 01 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphan Europe Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orphan Europe‘s full profile, request access.

Request a free trial

Orphan Europe Executive Team (1)

Name Title Board Seat Contact Info
Eric Pottier Chief Pharmaceutical Officer